Ena Ray Banerjee

Ena Ray Banerjee

University of Calcutta, India

Title: Translational medicine using clean green approach


Ena Ray Banerjee of University of Calcutta, Kolkata with expertise in Molecular Biology, Zoology, Aerobiology is on ResearchGate. She has more than 45 publications in reputed journals


Innovation is a key to fi nding aff ordable solution to pressing national needs in agriculture, health and energy. One must also stay competitive in the international market. In this context, a public-private partnership approach is unique in the sense that it permits a university, small business, or non-profi t institution to elect to pursue ownership of an invention in preference to the government. On the one hand the developed nations tapped in nature’s potential to unforeseen heights, and on the other, mother earth were vastly devastated as a result. So to echo the age old wisdom that with great power comes great responsibility, the onus is now on the scientist technocrat entrepreneurs to develop economically viable rapid turnaround customized technology which are biodegradable at the product level and eco-friendly at the process level. Green technology is thus the mantra of the day. Scientists working at the micro or macro level are thus guided by the twin principles of effi ciency and nature-friendly work philosophy. Products to improve or replace the old order and process to maximally tap the potential of a system and an inter-disciplinary approach is what should drive any happening organization, be it in the public or the private sector and a marriage of the two if possible or at least some cross-talk, to best utilize available resources to their full potency. Degenerative respiratory diseases such as Idiopathic Pulmonary Fibrosis, Pneumoconiosis and Asbestosis etc. are a major cause of mortality and morbidity worldwide and current treatments off er no prospect of cure or disease reversal. Human embryonic stem cell (hESC) provides a possible unlimited source of cells that could be diff erentiated into lung lineage specifi c cells for potential clinical use in pulmonary regenerative medicine. Th is study aims to tissue engineer pulmonary non-ciliated epithelial cells from hESC by guided endodermal diff erentiation in proprietorial specialized diff erentiation media supplemented with our own growth factor cocktail, mimicking the environment of lung development in embryo can be used for treatment of degenerative diseases of lung.

Speaker Presentations

Speaker PDFs